🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/03/2021 61,54 65,61 61,03 65,21 +3,80% 7,43% 1.204.100
24/03/2021 66,23 67,25 62,43 62,82 -4,92% 7,28% 810.200
23/03/2021 69,13 69,73 65,78 66,07 -6,28% 5,71% 730.500
22/03/2021 68,77 71,10 68,26 70,50 +4,60% 4,13% 803.500
19/03/2021 67,86 68,85 65,59 67,40 -0,65% 4,81% 2.059.000
18/03/2021 71,01 71,75 67,69 67,84 -6,52% 5,72% 692.600
17/03/2021 70,47 73,38 69,50 72,57 +0,83% 5,51% 461.200
16/03/2021 73,40 74,46 70,44 71,97 +0,17% 5,48% 525.100
15/03/2021 72,90 73,21 70,48 71,85 -1,22% 3,74% 802.300
12/03/2021 72,11 72,84 70,32 72,74 -0,60% 3,50% 513.200
11/03/2021 71,61 73,64 70,87 73,18 +5,10% 3,87% 659.000
10/03/2021 71,44 73,48 69,20 69,63 -0,34% 5,99% 732.300
09/03/2021 65,82 71,50 65,81 69,87 +8,19% 8,64% 913.200
08/03/2021 69,10 71,08 64,30 64,58 -6,41% 9,81% 1.191.200
05/03/2021 70,00 70,50 62,99 69,00 -0,81% 10,72% 1.614.000
04/03/2021 77,08 77,08 68,07 69,56 -7,84% 11,69% 1.767.600
03/03/2021 80,61 80,97 75,17 75,48 -6,39% 7,20% 900.300
02/03/2021 83,25 83,89 80,32 80,63 -3,76% 4,29% 722.700
01/03/2021 81,14 84,45 81,06 83,78 +5,17% 4,18% 567.600
26/02/2021 83,01 84,49 78,91 79,66 -3,09% 6,72% 1.061.700
25/02/2021 84,16 86,44 81,10 82,20 -3,33% 6,35% 615.100
24/02/2021 82,48 85,48 80,42 85,03 +4,01% 6,14% 697.500
23/02/2021 82,82 83,00 78,01 81,75 -3,82% 6,03% 1.327.300
22/02/2021 88,29 89,37 84,71 85,00 -5,04% 5,28% 791.600
19/02/2021 87,30 90,40 86,06 89,51 +3,53% 4,97% 679.100
18/02/2021 84,69 86,97 83,00 86,46 -0,28% 4,69% 749.000
17/02/2021 86,71 87,82 84,59 86,70 -0,80% 3,73% 850.900
16/02/2021 89,03 89,36 85,37 87,40 -0,91% 4,48% 565.800
12/02/2021 88,46 89,91 86,70 88,20 -0,16% 3,63% 489.200
11/02/2021 88,95 90,42 86,66 88,34 +0,98% 4,23% 610.700